CIK 0001501697 · Non-accelerated filer<br>Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273181608
- Phone
- 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 1 of 41 · 818 filings